Protease nexin. Properties and a modified purification procedure
about
Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous systemPlasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic TestingChronic obstructive pulmonary disease: towards pharmacogenetics.Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy casesHemostasis and alterations of the central nervous systemA potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma.SERPINE2 haplotype as a risk factor for panlobular type of emphysema.The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesisProtease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.The SERPINE2 gene is associated with chronic obstructive pulmonary disease.Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid depositsSERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.Involvement of the serine protease inhibitor, SERPINE2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation.Differential gene expression of serine protease inhibitors in bovine ovarian follicle: possible involvement in follicular growth and atresia.Urinary prostasin excretion is associated with adiposity in nonhypertensive African-American adolescents.The genetics of chronic obstructive pulmonary disease.Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin IUrokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.Activation of coagulation releases endothelial cell mitogensMesosecrin: a secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture.Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-betaA fast-acting elastase inhibitor in human monocytes.Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.Protease nexin-1, tPA, and PAI-1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis.Human fibroblasts accelerate the inhibition of thrombin by protease nexin.SERPINE2 polymorphisms and chronic obstructive pulmonary disease.Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Glycosaminoglycans and the regulation of blood coagulation.Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.Effect of heparin on the glia-derived-nexin-thrombin interaction.A simple two-step purification of protease nexin.Identification of a new tissue-kallikrein-binding protein.
P2860
Q26777276-5C3DAF5C-26C0-497D-9C4D-7895869AC7BFQ26801060-A1965FE0-8A77-48B5-8D01-302D2D7552AAQ33600138-9AB3E328-2F96-4B56-8D49-DE88CD300771Q33743565-E6994E31-8613-4522-B28D-B0EAD918A8E1Q33842161-D727B54D-19B0-42B2-BDBA-F631DBB13F41Q33849160-42AC0269-A5BB-4BA1-8022-F2DDDEDE2F57Q34092667-3BE4B2AE-6182-49DF-AE47-B8320BAAF91AQ34258429-03D348E6-F96E-4641-AED2-341799223CD7Q34315031-E07B2FCE-C055-49EB-A79F-ED40D0A3C139Q34331818-7BC2A080-6F5D-453C-8459-4BB17EA2B0D5Q34398902-3623CDD1-3E81-4937-B8B0-49DFBBD50DDFQ34671631-1AC63363-5148-42ED-909E-D5F6C1DABB86Q34748888-1F835738-ED4F-4C41-A742-1F7B53457CDBQ34983805-44D089B3-0AFE-4C0A-8320-C8BB63F5C1F4Q35052919-BCBD732F-C182-4F78-9A20-8448F8CDCE51Q35095140-80129EDC-ACCA-48AD-A51B-074DFEAC62C7Q35113365-1043196D-A7E9-4C97-A2E3-13FCD0D51CF6Q35590448-883ADF12-3D4E-40A4-8732-7B1A0F448029Q35594636-6CEA4791-50FE-4620-B1D1-1AD75E52609BQ35811925-2C8B9406-84E5-4D09-8A89-9EA8A43C41C8Q36213145-3DFD6F12-96F8-4C5E-8B39-429D9D7E9E87Q36215866-45C9F6A0-9749-4493-BAA0-1C857DF24764Q36216679-733F348D-8A20-42D9-80C8-4E4E958FBAC4Q36217085-F31B9916-9111-4E36-A7FE-18CD08AF422EQ36218283-B2BFFD24-1E21-4A86-A3C8-176821E67505Q36351353-311ADF5E-5AC2-4159-B53A-3744E7FDCA4BQ36353359-A080321A-E9E0-4729-A7F1-05294B62FAF3Q36356179-750EF829-5FF8-4216-9670-B1C37B69F2B4Q36430764-237AEF00-E2BD-4A26-9B56-6923ABA72F75Q36677380-B9EF6EBF-2F38-4308-8DD3-465E3CED5249Q37399239-6A46EDC7-B08D-4BF7-B326-408AD841869CQ37417954-4F54511C-F733-4E65-9669-9E1A1FEA6746Q39508019-CDDDB2DC-277C-4064-95F2-DD65F16A0410Q40851193-920478A9-B82F-456B-949F-F57BC495947FQ41362675-0BB62BF0-07E4-4AC8-8D6D-F17F2786EC26Q41514749-7AFF3FEF-17D9-4508-AF58-AFB32E2325EAQ41597026-E187A173-09DA-449C-8051-DDAD020AEE84Q42004743-94F9F506-8AA2-4EE1-9DB8-66351E417123Q42031140-5DE0F5C5-EAF2-44A2-B815-9A67C363A51AQ42165219-F39D844B-1251-4F55-A6E9-1B7464D737AB
P2860
Protease nexin. Properties and a modified purification procedure
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Protease nexin. Properties and a modified purification procedure
@ast
Protease nexin. Properties and a modified purification procedure
@en
Protease nexin. Properties and a modified purification procedure
@en-gb
Protease nexin. Properties and a modified purification procedure
@nl
type
label
Protease nexin. Properties and a modified purification procedure
@ast
Protease nexin. Properties and a modified purification procedure
@en
Protease nexin. Properties and a modified purification procedure
@en-gb
Protease nexin. Properties and a modified purification procedure
@nl
prefLabel
Protease nexin. Properties and a modified purification procedure
@ast
Protease nexin. Properties and a modified purification procedure
@en
Protease nexin. Properties and a modified purification procedure
@en-gb
Protease nexin. Properties and a modified purification procedure
@nl
P2093
P1476
Protease nexin. Properties and a modified purification procedure
@en
P2093
B L Bergman
H Rodriguez
P304
P407
P577
1985-06-10T00:00:00Z